Replies to post #3527 on GlobeStar Therapeutics Corp (GSTC)

[gempicker]

Well, the LOI reads like Diabetes Relief is going to dictate BOD, likely management and direction with Liprostin as only 7% royalty remains for originators..

Current CEO does not have background to lead either Diabetes Relief or Liprostin phase 3 clinicals.

Big things in store here...